NL-OMON31114尚未招募不适用
T and NK cell mediated immunotherapy in Ewing's sarcoma (P03.040 amended version of December 2006) - T and NK cell mediated immunotherapy in Ewing's sarcoma
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 99（—）
入选标准
- •All newly diagnosed Ewing's sarcoma patients in the LUMC.
排除标准
- •Lack of written informed consent
研究者
相似试验
招募中
不适用
T and NK cell mediated immunotherapy in osteosarcoma; a preclinical feasibility studybone tumors10040778NL-OMON30381Academisch Medisch Centrum25
未知
1 期
Immunotherapy with NK cellsClinical study to investigate safety and efficacy on NK cells to health and cancerJPRN-UMIN000002134Kuramae clinic15
招募中
不适用
Development of novel immunotherapy using NKT cells for malignant solid tumors in childreHealthy volunteersJPRN-UMIN000048076Chiba University30
已完成
不适用
ext-Generation Therapy for NK/T-cell lymphoma in East Asia: a multicenter retrospective study in Japan for the next stepExtranodal NK/T-cell lymphoma, nasal type (ENKL)JPRN-UMIN000046300Mie University368
已完成
不适用
ext-Generation Therapy for NK/T-cell lymphoma in East Asia: a multi-institutional retrospective studyExtranodal NK/T-cell lymphoma, nasal type (ENKL)JPRN-UMIN000015491Department of Hematology and Oncology, Mie University Graduate School of Medicine400